APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icodec Insulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Icodec Insulin Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchIcodec Insulin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Icodec Insulin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Icodec Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icodec Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Icodec Insulin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icodec Insulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icodec Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Icodec Insulin include Paijin Biotechnology, Sanofi, Lilly, Gan&Lee Pharmaceuticals and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Icodec Insulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Icodec Insulin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Icodec Insulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Icodec Insulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Icodec Insulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Icodec Insulin Market by Company

Paijin Biotechnology

Sanofi

Lilly

Gan&Lee Pharmaceuticals

Novo Nordisk

Icodec Insulin Segment by Type

Long-acting

Medium-acting

Icodec Insulin Segment by Application

Hospital

Clinic

Icodec Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icodec Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icodec Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icodec Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Icodec Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Icodec Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long-acting Table 2. Major Company of Medium-acting Table 3. Global Icodec Insulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 5. Global Icodec Insulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Icodec Insulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Icodec Insulin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 10. Global Icodec Insulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Icodec Insulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Icodec Insulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Icodec Insulin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 15. North America Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 17. Europe Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Icodec Insulin Sales by Type (2021-2026) & (US$ Million) Table 24. Icodec Insulin Industry Trends Table 25. Icodec Insulin Industry Drivers Table 26. Icodec Insulin Industry Opportunities and Challenges Table 27. Icodec Insulin Industry Restraints Table 28. Global Icodec Insulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Icodec Insulin Revenue Market Share by Company (2021-2026) Table 30. Global Icodec Insulin Sales by Company (2021-2026) & (K Units) Table 31. Global Icodec Insulin Sales Share by Company (2021-2026) Table 32. Global Icodec Insulin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Icodec Insulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Icodec Insulin Major Company Production Sites and Headquarters Table 35. Global Icodec Insulin Company, Product Type & Application Table 36. Global Icodec Insulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Icodec Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Icodec Insulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Icodec Insulin Sales by Region (2021-2026) & (K Units) Table 41. Global Icodec Insulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Icodec Insulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Icodec Insulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Icodec Insulin Sales by Region (2027-2032) & (K Units) Table 46. Global Icodec Insulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Icodec Insulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Icodec Insulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Icodec Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Icodec Insulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 52. Global Icodec Insulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Icodec Insulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Icodec Insulin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 57. Global Icodec Insulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Icodec Insulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Icodec Insulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Icodec Insulin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 62. North America Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 64. Europe Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Icodec Insulin Sales by Application (2021-2026) & (US$ Million) Table 71. Paijin Biotechnology Company Information Table 72. Paijin Biotechnology Business Overview Table 73. Paijin Biotechnology Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Paijin Biotechnology Icodec Insulin Product Portfolio Table 75. Paijin Biotechnology Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Icodec Insulin Product Portfolio Table 80. Sanofi Recent Development Table 81. Lilly Company Information Table 82. Lilly Business Overview Table 83. Lilly Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lilly Icodec Insulin Product Portfolio Table 85. Lilly Recent Development Table 86. Gan&Lee Pharmaceuticals Company Information Table 87. Gan&Lee Pharmaceuticals Business Overview Table 88. Gan&Lee Pharmaceuticals Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio Table 90. Gan&Lee Pharmaceuticals Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novo Nordisk Icodec Insulin Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. North America Icodec Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 98. North America Icodec Insulin Sales Market Share by Country (2021-2026) Table 99. North America Icodec Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Icodec Insulin Sales Market Share Forecast by Country (2027-2032) Table 101. North America Icodec Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Icodec Insulin Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Icodec Insulin Market Share by Country (2021-2026) Table 104. North America Icodec Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Icodec Insulin Market Share Forecast by Country (2027-2032) Table 106. Europe Icodec Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 108. Europe Icodec Insulin Sales Market Share by Country (2021-2026) Table 109. Europe Icodec Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Icodec Insulin Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Icodec Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Icodec Insulin Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Icodec Insulin Market Share by Country (2021-2026) Table 114. Europe Icodec Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Icodec Insulin Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Icodec Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Icodec Insulin Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Icodec Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Icodec Insulin Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Icodec Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Icodec Insulin Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Icodec Insulin Market Share by Country (2021-2026) Table 124. Asia-Pacific Icodec Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Icodec Insulin Market Share Forecast by Country (2027-2032) Table 126. Latin America Icodec Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 128. Latin America Icodec Insulin Sales Market Share by Country (2021-2026) Table 129. Latin America Icodec Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Icodec Insulin Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Icodec Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Icodec Insulin Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Icodec Insulin Market Share by Country (2021-2026) Table 134. Latin America Icodec Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Icodec Insulin Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Icodec Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Icodec Insulin Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Icodec Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Icodec Insulin Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Icodec Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Icodec Insulin Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Icodec Insulin Market Share by Country (2021-2026) Table 144. Middle East and Africa Icodec Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Icodec Insulin Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Icodec Insulin Distributors List Table 149. Icodec Insulin Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Icodec Insulin Image Figure 2. Global Icodec Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icodec Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Icodec Insulin Sales (2021-2032) & (K Units) Figure 5. Long-acting Image Figure 6. Global Long-acting Sales YoY Growth (2021-2032) & (K Units) Figure 7. Medium-acting Image Figure 8. Global Medium-acting Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Icodec Insulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Icodec Insulin Market Share by Type 2025 VS 2032 Figure 11. North America Icodec Insulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Icodec Insulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Icodec Insulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Icodec Insulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Icodec Insulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Icodec Insulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Icodec Insulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Icodec Insulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Icodec Insulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Icodec Insulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Icodec Insulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Icodec Insulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Icodec Insulin Market Share by Application 2025 VS 2032 Figure 29. North America Icodec Insulin Sales Market Share in Volume by Application in 2025 Figure 30. North America Icodec Insulin Sales Market Share in Value by Application in 2025 Figure 31. Europe Icodec Insulin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Icodec Insulin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Icodec Insulin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Icodec Insulin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Icodec Insulin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Icodec Insulin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Icodec Insulin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Icodec Insulin Sales Market Share in Value by Application in 2025 Figure 39. North America Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Icodec Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Icodec Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Icodec Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Icodec Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Icodec Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Icodec Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Icodec Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Icodec Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Icodec Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Icodec Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Icodec Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Icodec Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Icodec Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Icodec Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Icodec Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Icodec Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Icodec Insulin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Icodec Insulin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Long-acting
  • Medium-acting
Applications
  • Hospital
  • Clinic
Companies covered
  • Paijin Biotechnology
  • Sanofi
  • Lilly
  • Gan&Lee Pharmaceuticals
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icodec Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Icodec Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Icodec Insulin Market by Type
  6. 1.3.1 Long-acting
  7. 1.3.2 Medium-acting
  8. 1.4 Global Icodec Insulin Market Size by Type
  9. 1.4.1 Global Icodec Insulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Icodec Insulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Icodec Insulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Icodec Insulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Icodec Insulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Icodec Insulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Icodec Insulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Icodec Insulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Icodec Insulin Industry Trends
  2. 2.2 Icodec Insulin Industry Drivers
  3. 2.3 Icodec Insulin Industry Opportunities and Challenges
  4. 2.4 Icodec Insulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Icodec Insulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Icodec Insulin Sales (2021-2026)
  3. 3.3 Global Top Players by Icodec Insulin Price (2021-2026)
  4. 3.4 Global Icodec Insulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Icodec Insulin Major Company Production Sites & Headquarters
  6. 3.6 Global Icodec Insulin Company, Product Type & Application
  7. 3.7 Global Icodec Insulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Icodec Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Icodec Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Icodec Insulin Tier 1, Tier 2, and Tier 3
4 Icodec Insulin Regional Status and Outlook
  1. 4.1 Global Icodec Insulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Icodec Insulin Historic Market Size by Region
  3. 4.2.1 Global Icodec Insulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Icodec Insulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Icodec Insulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Icodec Insulin Forecasted Market Size by Region
  7. 4.3.1 Global Icodec Insulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Icodec Insulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Icodec Insulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Icodec Insulin by Application
  1. 5.1 Icodec Insulin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Icodec Insulin Market Size by Application
  5. 5.2.1 Global Icodec Insulin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Icodec Insulin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Icodec Insulin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Icodec Insulin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Icodec Insulin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Icodec Insulin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Icodec Insulin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Icodec Insulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Paijin Biotechnology
  2. 6.1.1 Paijin Biotechnology Company Information
  3. 6.1.2 Paijin Biotechnology Business Overview
  4. 6.1.3 Paijin Biotechnology Icodec Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Paijin Biotechnology Icodec Insulin Product Portfolio
  6. 6.1.5 Paijin Biotechnology Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Icodec Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Icodec Insulin Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Lilly
  14. 6.3.1 Lilly Company Information
  15. 6.3.2 Lilly Business Overview
  16. 6.3.3 Lilly Icodec Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lilly Icodec Insulin Product Portfolio
  18. 6.3.5 Lilly Recent Developments
  19. 6.4 Gan&Lee Pharmaceuticals
  20. 6.4.1 Gan&Lee Pharmaceuticals Company Information
  21. 6.4.2 Gan&Lee Pharmaceuticals Business Overview
  22. 6.4.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio
  24. 6.4.5 Gan&Lee Pharmaceuticals Recent Developments
  25. 6.5 Novo Nordisk
  26. 6.5.1 Novo Nordisk Company Information
  27. 6.5.2 Novo Nordisk Business Overview
  28. 6.5.3 Novo Nordisk Icodec Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novo Nordisk Icodec Insulin Product Portfolio
  30. 6.5.5 Novo Nordisk Recent Developments
7 North America by Country
  1. 7.1 North America Icodec Insulin Sales by Country
  2. 7.1.1 North America Icodec Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Icodec Insulin Sales by Country (2021-2026)
  4. 7.1.3 North America Icodec Insulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Icodec Insulin Market Size by Country
  6. 7.2.1 North America Icodec Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Icodec Insulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Icodec Insulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Icodec Insulin Sales by Country
  2. 8.1.1 Europe Icodec Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Icodec Insulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Icodec Insulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Icodec Insulin Market Size by Country
  6. 8.2.1 Europe Icodec Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Icodec Insulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Icodec Insulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Icodec Insulin Sales by Country
  2. 9.1.1 Asia-Pacific Icodec Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Icodec Insulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Icodec Insulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Icodec Insulin Market Size by Country
  6. 9.2.1 Asia-Pacific Icodec Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Icodec Insulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Icodec Insulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Icodec Insulin Sales by Country
  2. 10.1.1 South America Icodec Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Icodec Insulin Sales by Country (2021-2026)
  4. 10.1.3 South America Icodec Insulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Icodec Insulin Market Size by Country
  6. 10.2.1 South America Icodec Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Icodec Insulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Icodec Insulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Icodec Insulin Sales by Country
  2. 11.1.1 Middle East and Africa Icodec Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Icodec Insulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Icodec Insulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Icodec Insulin Market Size by Country
  6. 11.2.1 Middle East and Africa Icodec Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Icodec Insulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Icodec Insulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Icodec Insulin Value Chain Analysis
  2. 12.1.1 Icodec Insulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Icodec Insulin Production Mode & Process
  7. 12.2 Icodec Insulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Icodec Insulin Distributors
  10. 12.2.3 Icodec Insulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst